| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.80e-05 | 10 | 108 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 6.68e-05 | 15 | 108 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | FAD binding | 9.30e-05 | 44 | 108 | 4 | GO:0071949 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.40e-04 | 19 | 108 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | protein-phosphatidylethanolamide deconjugating activity | 1.73e-04 | 4 | 108 | 2 | GO:0019786 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 AKT3 FLT3 EPHA6 PDK3 CAMK2A PIK3C3 AKT1 AKT2 WNK4 EPHA7 | 4.07e-04 | 600 | 108 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 4.09e-04 | 27 | 108 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.25e-04 | 65 | 108 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 AKT3 FLT3 EPHA6 PDK3 CAMK2A ITPKC PIK3C3 AKT1 AKT2 WNK4 EPHA7 | 4.53e-04 | 709 | 108 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 5.98e-04 | 7 | 108 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | taste receptor activity | 7.46e-04 | 33 | 108 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 7.94e-04 | 8 | 108 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 AKT3 FLT3 EPHA6 PDK3 CAMK2A ITPKC PIK3C3 AKT1 AKT2 WNK4 EPHA7 | 8.72e-04 | 764 | 108 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 1.02e-03 | 9 | 108 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.17e-03 | 85 | 108 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 1.54e-03 | 11 | 108 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.70e-03 | 94 | 108 | 4 | GO:0050660 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell development | 1.63e-05 | 10 | 108 | 3 | GO:2000074 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of Sertoli cell barrier | 2.72e-05 | 2 | 108 | 2 | GO:1904446 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 2.97e-05 | 12 | 108 | 3 | GO:0015911 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 3.31e-05 | 70 | 108 | 5 | GO:0009311 | |
| GeneOntologyBiologicalProcess | response to insulin-like growth factor stimulus | 8.12e-05 | 3 | 108 | 2 | GO:1990418 | |
| GeneOntologyBiologicalProcess | regulation of establishment of Sertoli cell barrier | 8.12e-05 | 3 | 108 | 2 | GO:1904444 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.00e-04 | 275 | 108 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 1.49e-04 | 20 | 108 | 3 | GO:0044539 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 1.62e-04 | 4 | 108 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 1.62e-04 | 4 | 108 | 2 | GO:0140213 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 1.91e-04 | 101 | 108 | 5 | GO:0002028 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 2.00e-04 | 22 | 108 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 2.61e-04 | 24 | 108 | 3 | GO:0031290 | |
| GeneOntologyBiologicalProcess | negative regulation of superoxide anion generation | 2.69e-04 | 5 | 108 | 2 | GO:0032929 | |
| GeneOntologyBiologicalProcess | protein delipidation | 2.69e-04 | 5 | 108 | 2 | GO:0051697 | |
| GeneOntologyBiologicalProcess | lipid import into cell | 2.95e-04 | 25 | 108 | 3 | GO:0140354 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 2.95e-04 | 25 | 108 | 3 | GO:0055064 | |
| Domain | TF_fork_head_CS_2 | 5.82e-06 | 46 | 105 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 6.49e-06 | 47 | 105 | 5 | IPR018122 | |
| Domain | FH | 7.99e-06 | 49 | 105 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 7.99e-06 | 49 | 105 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 7.99e-06 | 49 | 105 | 5 | PS00658 | |
| Domain | Fork_head_dom | 7.99e-06 | 49 | 105 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 7.99e-06 | 49 | 105 | 5 | PS50039 | |
| Domain | Forkhead | 7.99e-06 | 49 | 105 | 5 | PF00250 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.01e-05 | 14 | 105 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.01e-05 | 14 | 105 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.01e-05 | 14 | 105 | 3 | IPR001426 | |
| Domain | EphA2_TM | 6.01e-05 | 14 | 105 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.01e-05 | 14 | 105 | 3 | IPR001090 | |
| Domain | Eph_TM | 6.01e-05 | 14 | 105 | 3 | IPR027936 | |
| Domain | EPH_lbd | 6.01e-05 | 14 | 105 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 6.01e-05 | 14 | 105 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.01e-05 | 14 | 105 | 3 | IPR016257 | |
| Domain | EPH_LBD | 6.01e-05 | 14 | 105 | 3 | PS51550 | |
| Domain | RFX1_trans_act | 9.36e-05 | 3 | 105 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 9.36e-05 | 3 | 105 | 2 | PF04589 | |
| Domain | VDCC_a2/dsu | 1.86e-04 | 4 | 105 | 2 | IPR013680 | |
| Domain | Peptidase_C54 | 1.86e-04 | 4 | 105 | 2 | PF03416 | |
| Domain | VGCC_alpha2 | 1.86e-04 | 4 | 105 | 2 | PF08473 | |
| Domain | Peptidase_C54 | 1.86e-04 | 4 | 105 | 2 | IPR005078 | |
| Domain | Multidrug-R_assoc | 1.86e-04 | 4 | 105 | 2 | IPR005292 | |
| Domain | - | 2.32e-04 | 218 | 105 | 7 | 1.10.10.10 | |
| Domain | VWA_N | 3.10e-04 | 5 | 105 | 2 | IPR013608 | |
| Domain | VWA_N | 3.10e-04 | 5 | 105 | 2 | PF08399 | |
| Domain | ABC_membrane | 3.21e-04 | 24 | 105 | 3 | PF00664 | |
| Domain | Ephrin_rec_like | 3.63e-04 | 25 | 105 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.63e-04 | 25 | 105 | 3 | IPR011641 | |
| Domain | TAS2R | 4.09e-04 | 26 | 105 | 3 | PF05296 | |
| Domain | T2R | 4.09e-04 | 26 | 105 | 3 | IPR007960 | |
| Domain | WHTH_DNA-bd_dom | 4.36e-04 | 242 | 105 | 7 | IPR011991 | |
| Domain | - | 4.63e-04 | 6 | 105 | 2 | 3.30.465.10 | |
| Domain | FAD_PCMH | 4.63e-04 | 6 | 105 | 2 | PS51387 | |
| Domain | CO_DH_flavot_FAD-bd_sub2 | 4.63e-04 | 6 | 105 | 2 | IPR016169 | |
| Domain | FAD-bd_2 | 4.63e-04 | 6 | 105 | 2 | IPR016166 | |
| Domain | ABC_TM1F | 5.11e-04 | 28 | 105 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 5.11e-04 | 28 | 105 | 3 | IPR011527 | |
| Domain | SAM_1 | 5.83e-04 | 68 | 105 | 4 | PF00536 | |
| Domain | MHC_II_b_N | 8.57e-04 | 8 | 105 | 2 | PD000328 | |
| Domain | Kinase-like_dom | 9.53e-04 | 542 | 105 | 10 | IPR011009 | |
| Domain | MHC_II_b_N | 1.10e-03 | 9 | 105 | 2 | IPR000353 | |
| Domain | MYTH4 | 1.10e-03 | 9 | 105 | 2 | PS51016 | |
| Domain | MHC_II_beta | 1.10e-03 | 9 | 105 | 2 | SM00921 | |
| Domain | MyTH4 | 1.10e-03 | 9 | 105 | 2 | SM00139 | |
| Domain | MHC_II_beta | 1.10e-03 | 9 | 105 | 2 | PF00969 | |
| Domain | MyTH4_dom | 1.10e-03 | 9 | 105 | 2 | IPR000857 | |
| Domain | MyTH4 | 1.10e-03 | 9 | 105 | 2 | PF00784 | |
| Domain | RFX_DNA_binding | 1.10e-03 | 9 | 105 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 1.10e-03 | 9 | 105 | 2 | IPR003150 | |
| Domain | RFX_DBD | 1.10e-03 | 9 | 105 | 2 | PS51526 | |
| Domain | PROTEIN_KINASE_ATP | 1.13e-03 | 459 | 105 | 9 | PS00107 | |
| Domain | Pkinase_C | 1.17e-03 | 37 | 105 | 3 | IPR017892 | |
| Domain | Protein_kinase_ATP_BS | 1.35e-03 | 379 | 105 | 8 | IPR017441 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 1.37e-03 | 10 | 105 | 2 | IPR001709 | |
| Domain | Tyr_kinase_cat_dom | 1.53e-03 | 88 | 105 | 4 | IPR020635 | |
| Domain | TyrKc | 1.53e-03 | 88 | 105 | 4 | SM00219 | |
| Domain | Ephrin_rec_like | 1.67e-03 | 11 | 105 | 2 | PF07699 | |
| Domain | Pkinase_C | 1.69e-03 | 42 | 105 | 3 | PF00433 | |
| Domain | ABC_transporter_CS | 1.69e-03 | 42 | 105 | 3 | IPR017871 | |
| Domain | Prot_kinase_dom | 1.75e-03 | 489 | 105 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.85e-03 | 493 | 105 | 9 | PS50011 | |
| Domain | OxRdtase_FAD/NAD-bd | 1.99e-03 | 12 | 105 | 2 | IPR001433 | |
| Domain | NAD_binding_1 | 1.99e-03 | 12 | 105 | 2 | PF00175 | |
| Domain | SAM_DOMAIN | 2.03e-03 | 95 | 105 | 4 | PS50105 | |
| Domain | PROTEIN_KINASE_TYR | 2.19e-03 | 97 | 105 | 4 | PS00109 | |
| Domain | SAM | 2.19e-03 | 97 | 105 | 4 | IPR001660 | |
| Domain | Tyr_kinase_AS | 2.19e-03 | 97 | 105 | 4 | IPR008266 | |
| Domain | FERM_M | 2.20e-03 | 46 | 105 | 3 | PF00373 | |
| Domain | ABC_tran | 2.49e-03 | 48 | 105 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.49e-03 | 48 | 105 | 3 | PS50893 | |
| Domain | - | 2.64e-03 | 49 | 105 | 3 | 1.20.80.10 | |
| Domain | ABC_TRANSPORTER_1 | 2.64e-03 | 49 | 105 | 3 | PS00211 | |
| Domain | FERM_central | 2.64e-03 | 49 | 105 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.64e-03 | 49 | 105 | 3 | IPR000299 | |
| Domain | MHC_II_a/b_N | 2.73e-03 | 14 | 105 | 2 | IPR014745 | |
| Domain | - | 2.73e-03 | 14 | 105 | 2 | 3.10.320.10 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.79e-03 | 50 | 105 | 3 | IPR014352 | |
| Domain | ABC_transporter-like | 2.79e-03 | 50 | 105 | 3 | IPR003439 | |
| Domain | FERM_1 | 2.79e-03 | 50 | 105 | 3 | PS00660 | |
| Domain | FERM_2 | 2.79e-03 | 50 | 105 | 3 | PS00661 | |
| Domain | FERM_3 | 2.79e-03 | 50 | 105 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.79e-03 | 50 | 105 | 3 | IPR019749 | |
| Domain | B41 | 2.79e-03 | 50 | 105 | 3 | SM00295 | |
| Domain | - | 3.02e-03 | 106 | 105 | 4 | 1.10.150.50 | |
| Domain | AGC-kinase_C | 3.86e-03 | 56 | 105 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.86e-03 | 56 | 105 | 3 | PS51285 | |
| Domain | S_TK_X | 3.86e-03 | 56 | 105 | 3 | SM00133 | |
| Domain | Gal_mutarotase_SF_dom | 4.03e-03 | 17 | 105 | 2 | IPR011013 | |
| Domain | SAM/pointed | 4.30e-03 | 117 | 105 | 4 | IPR013761 | |
| Domain | Fd_Rdtase_FAD-bd | 5.03e-03 | 19 | 105 | 2 | IPR017927 | |
| Domain | FAD_FR | 5.03e-03 | 19 | 105 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 5.03e-03 | 19 | 105 | 2 | IPR017938 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.07e-06 | 14 | 83 | 4 | M47390 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.45e-06 | 15 | 83 | 4 | M47475 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 1.95e-06 | 5 | 83 | 3 | M48999 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 3.89e-06 | 6 | 83 | 3 | M47523 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 6.77e-06 | 7 | 83 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 6.77e-06 | 7 | 83 | 3 | M47790 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.08e-05 | 8 | 83 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.08e-05 | 8 | 83 | 3 | M47715 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.61e-05 | 9 | 83 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 1.61e-05 | 9 | 83 | 3 | M47972 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.29e-05 | 10 | 83 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 2.29e-05 | 10 | 83 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 2.29e-05 | 10 | 83 | 3 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.29e-05 | 10 | 83 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.29e-05 | 10 | 83 | 3 | MM14778 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 3.14e-05 | 11 | 83 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.14e-05 | 11 | 83 | 3 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 4.17e-05 | 12 | 83 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 4.17e-05 | 12 | 83 | 3 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 4.17e-05 | 12 | 83 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 4.17e-05 | 12 | 83 | 3 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 4.17e-05 | 12 | 83 | 3 | M45022 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 4.17e-05 | 12 | 83 | 3 | M39611 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.17e-05 | 12 | 83 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.17e-05 | 12 | 83 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 4.17e-05 | 12 | 83 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 4.17e-05 | 12 | 83 | 3 | MM14550 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 5.39e-05 | 13 | 83 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 5.39e-05 | 13 | 83 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 5.39e-05 | 13 | 83 | 3 | M549 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 6.84e-05 | 14 | 83 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 6.84e-05 | 14 | 83 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 6.84e-05 | 14 | 83 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 6.84e-05 | 14 | 83 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 6.84e-05 | 14 | 83 | 3 | M3862 | |
| Pathway | REACTOME_FLT3_SIGNALING | 7.08e-05 | 38 | 83 | 4 | M29803 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 7.34e-05 | 74 | 83 | 5 | M17386 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 8.51e-05 | 15 | 83 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 8.51e-05 | 15 | 83 | 3 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 8.51e-05 | 15 | 83 | 3 | M26902 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 8.51e-05 | 15 | 83 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 8.51e-05 | 15 | 83 | 3 | M47971 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 8.69e-05 | 40 | 83 | 4 | M39798 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.16e-04 | 43 | 83 | 4 | M39788 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 1.26e-04 | 17 | 83 | 3 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 1.26e-04 | 17 | 83 | 3 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 1.26e-04 | 17 | 83 | 3 | M18895 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.78e-04 | 19 | 83 | 3 | M39370 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 1.78e-04 | 19 | 83 | 3 | M16991 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.78e-04 | 19 | 83 | 3 | M47525 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.09e-04 | 50 | 83 | 4 | M48087 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 2.42e-04 | 21 | 83 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.42e-04 | 21 | 83 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.42e-04 | 21 | 83 | 3 | MM14996 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.80e-04 | 22 | 83 | 3 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.80e-04 | 22 | 83 | 3 | MM15656 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 2.80e-04 | 22 | 83 | 3 | M47919 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.91e-04 | 99 | 83 | 5 | MM14986 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 3.20e-04 | 23 | 83 | 3 | MM15952 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 3.20e-04 | 23 | 83 | 3 | M46455 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 3.20e-04 | 23 | 83 | 3 | MM14993 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 3.48e-04 | 57 | 83 | 4 | M19888 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 3.49e-04 | 103 | 83 | 5 | M758 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 3.64e-04 | 24 | 83 | 3 | M27952 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 3.64e-04 | 24 | 83 | 3 | M47460 | |
| Pathway | WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN | 4.12e-04 | 25 | 83 | 3 | M39533 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 4.12e-04 | 25 | 83 | 3 | M39794 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 4.12e-04 | 25 | 83 | 3 | M39384 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 4.12e-04 | 25 | 83 | 3 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 4.64e-04 | 26 | 83 | 3 | MM15017 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 4.64e-04 | 26 | 83 | 3 | M27558 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 4.64e-04 | 26 | 83 | 3 | MM15501 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 4.64e-04 | 26 | 83 | 3 | M48092 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 4.64e-04 | 26 | 83 | 3 | M47456 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.20e-04 | 27 | 83 | 3 | M27422 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 5.20e-04 | 27 | 83 | 3 | M1718 | |
| Pathway | KEGG_GLIOMA | 5.76e-04 | 65 | 83 | 4 | M1835 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 6.10e-04 | 66 | 83 | 4 | MM14990 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 6.44e-04 | 29 | 83 | 3 | M27756 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 1.41e-09 | 6 | 110 | 4 | 31996678 | |
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 1.41e-09 | 6 | 110 | 4 | 27092474 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 6.57e-09 | 8 | 110 | 4 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 1.18e-08 | 9 | 110 | 4 | 12412011 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 3.08e-08 | 3 | 110 | 3 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 3.08e-08 | 3 | 110 | 3 | 38528080 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 15987444 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 19825827 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 3.08e-08 | 3 | 110 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 3.08e-08 | 3 | 110 | 3 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 3.08e-08 | 3 | 110 | 3 | 25037569 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 3.08e-08 | 3 | 110 | 3 | 29173281 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 21590431 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 29235817 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 3.08e-08 | 3 | 110 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 3.08e-08 | 3 | 110 | 3 | 24722238 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 24039187 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 16923958 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17202487 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 26953242 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17577629 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 23929892 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 19805051 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 25233414 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 21555366 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 32796067 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 3.08e-08 | 3 | 110 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 3.08e-08 | 3 | 110 | 3 | 27098694 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 28931550 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 10579998 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 20398329 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 3.08e-08 | 3 | 110 | 3 | 20018949 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 24247267 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17895832 | ||
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 3.08e-08 | 3 | 110 | 3 | 10491192 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 3.08e-08 | 3 | 110 | 3 | 15713641 | |
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 9394803 | ||
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 6.63e-08 | 13 | 110 | 4 | 16884697 | |
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 7957066 | ||
| Pubmed | 9.25e-08 | 14 | 110 | 4 | 17157319 | ||
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 1.23e-07 | 4 | 110 | 3 | 31552693 | |
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 1.23e-07 | 4 | 110 | 3 | 19933838 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 21242979 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 19435822 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 21507933 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 1.23e-07 | 4 | 110 | 3 | 26227811 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 17942896 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 30567482 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 21763505 | ||
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 1.26e-07 | 15 | 110 | 4 | 7689224 | |
| Pubmed | 1.26e-07 | 15 | 110 | 4 | 22045912 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 1.67e-07 | 16 | 110 | 4 | 8861101 | |
| Pubmed | 1.67e-07 | 16 | 110 | 4 | 21029719 | ||
| Pubmed | 1.67e-07 | 16 | 110 | 4 | 20818790 | ||
| Pubmed | 1.67e-07 | 16 | 110 | 4 | 10208738 | ||
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 1.67e-07 | 16 | 110 | 4 | 16524887 | |
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 3.06e-07 | 5 | 110 | 3 | 20059950 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 9512493 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 29153407 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 27938661 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 3.06e-07 | 5 | 110 | 3 | 17442925 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 22814751 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 29378301 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 12234674 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 3.06e-07 | 5 | 110 | 3 | 19289493 | |
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 3.06e-07 | 5 | 110 | 3 | 18300076 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 25246356 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 3.06e-07 | 5 | 110 | 3 | 30833219 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 3.06e-07 | 5 | 110 | 3 | 26996309 | |
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 3.54e-07 | 19 | 110 | 4 | 9895322 | |
| Pubmed | 4.41e-07 | 20 | 110 | 4 | 12812790 | ||
| Pubmed | 5.44e-07 | 21 | 110 | 4 | 9449667 | ||
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 6.11e-07 | 6 | 110 | 3 | 24642468 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 6.11e-07 | 6 | 110 | 3 | 24156551 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 14749824 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 23746211 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 6.11e-07 | 6 | 110 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 6.11e-07 | 6 | 110 | 3 | 10869418 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 6.11e-07 | 6 | 110 | 3 | 34385359 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 15616007 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 23673657 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 6.11e-07 | 6 | 110 | 3 | 11707444 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 6.11e-07 | 6 | 110 | 3 | 12783884 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 18160256 | ||
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 6.11e-07 | 6 | 110 | 3 | 17439945 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 20186503 | ||
| Pubmed | 6.63e-07 | 22 | 110 | 4 | 11994280 | ||
| Pubmed | 6.63e-07 | 22 | 110 | 4 | 17389379 | ||
| Cytoband | 9q21.11 | 8.15e-07 | 30 | 110 | 4 | 9q21.11 | |
| GeneFamily | ATP binding cassette subfamily C | 1.55e-05 | 13 | 70 | 3 | 807 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.96e-05 | 14 | 70 | 3 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 3.76e-04 | 88 | 70 | 4 | 760 | |
| GeneFamily | Regulatory factor X family | 4.08e-04 | 8 | 70 | 2 | 1153 | |
| GeneFamily | Taste 2 receptors | 4.60e-04 | 39 | 70 | 3 | 1162 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.56e-04 | 50 | 70 | 3 | 1293 | |
| GeneFamily | Fibronectin type III domain containing | 3.44e-03 | 160 | 70 | 4 | 555 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.52e-03 | 26 | 70 | 2 | 253 | |
| GeneFamily | Autophagy related | 7.22e-03 | 33 | 70 | 2 | 1022 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.35e-03 | 206 | 70 | 4 | 682 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | EPHB2 AKT3 GANC CACNA2D2 HLA-DQB1 CAMK2A SPTAN1 BCHE RFX2 RFX3 KIF24 GJA1 SINHCAF NTNG2 BRCA2 DHCR24 TTI1 AKT2 TMEM143 SLC12A7 NIPBL | 1.54e-06 | 1370 | 101 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 157 | 109 | 6 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 157 | 109 | 6 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.43e-06 | 180 | 109 | 6 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.43e-06 | 180 | 109 | 6 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.43e-06 | 180 | 109 | 6 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 3.30e-05 | 149 | 109 | 5 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 154 | 109 | 5 | f29316d4b4dcdb23bd427d78068e65a9802f7f07 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 154 | 109 | 5 | 66065c0763c83d98084ca6969694c3af37e43274 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 5.52e-05 | 166 | 109 | 5 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.52e-05 | 166 | 109 | 5 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.52e-05 | 166 | 109 | 5 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.52e-05 | 166 | 109 | 5 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.84e-05 | 168 | 109 | 5 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC1|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-05 | 171 | 109 | 5 | 459e1ac0b89571c39db98c0f578eca8f46caa8e3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 174 | 109 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 177 | 109 | 5 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 178 | 109 | 5 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 8.09e-05 | 180 | 109 | 5 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 8.30e-05 | 181 | 109 | 5 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 8.30e-05 | 181 | 109 | 5 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 183 | 109 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.75e-05 | 183 | 109 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.75e-05 | 183 | 109 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-05 | 184 | 109 | 5 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.20e-05 | 185 | 109 | 5 | 8f843badc0e26cb7300c83db56c7974beb90fcf3 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 9.20e-05 | 185 | 109 | 5 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.44e-05 | 186 | 109 | 5 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.68e-05 | 187 | 109 | 5 | 8249b2a69c728e4e04fb14b490c320e644d2252f | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.04e-04 | 190 | 109 | 5 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.07e-04 | 191 | 109 | 5 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 191 | 109 | 5 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-04 | 191 | 109 | 5 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 191 | 109 | 5 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 191 | 109 | 5 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 192 | 109 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-04 | 193 | 109 | 5 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.15e-04 | 194 | 109 | 5 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.15e-04 | 194 | 109 | 5 | 6a9bb5ad04aba13a4886fa27a96e28e90b6586e3 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.18e-04 | 195 | 109 | 5 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.18e-04 | 195 | 109 | 5 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Unfolded_protein_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-04 | 195 | 109 | 5 | 9873de83b67e9645112897d3391c2d9afaa9970e | |
| ToppCell | wk_15-18-Hematologic-Myeloid-DC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 195 | 109 | 5 | 143093edefb3da63bb10adb1f5ea6e250a524ac2 | |
| ToppCell | AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 195 | 109 | 5 | bb45a17871a8a2593bc16a95f22e3c239c49985b | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.18e-04 | 195 | 109 | 5 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 196 | 109 | 5 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 196 | 109 | 5 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 196 | 109 | 5 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 196 | 109 | 5 | 006d783a530aa6e1e6545dcc2e6b00bb300fe070 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 197 | 109 | 5 | 89fe4885efc8db142c0dc0506840ae8aceba9ef9 | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | 8e5ac110278461af6eceec1e04de02df8430d1d7 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | f44eb16695ea52e3f99073f5976590069b1d9c5a | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-04 | 199 | 109 | 5 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 199 | 109 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 109 | 5 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| Drug | Texas Red | 8.98e-06 | 28 | 108 | 4 | CID000452705 | |
| Drug | mercury | ABCC1 CACNA2D2 ACP5 CFTR AOX1 BCHE LCT PHEX CACNA2D4 PIK3C3 AKT2 ABCC2 | 1.03e-05 | 542 | 108 | 12 | CID000023931 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.64e-05 | 308 | 108 | 9 | CID000001915 | |
| Drug | benzyl-beta-lactoside | 2.23e-05 | 2 | 108 | 2 | CID003462525 | |
| Drug | Heptanol | 2.23e-05 | 2 | 108 | 2 | ctd:D019850 | |
| Drug | Sulfinpyrazone | 2.23e-05 | 2 | 108 | 2 | DB01138 | |
| Drug | glutathione-BPDE conjugate | 2.23e-05 | 2 | 108 | 2 | ctd:C113118 | |
| Drug | robinetin | 2.23e-05 | 2 | 108 | 2 | ctd:C040014 | |
| Drug | Fluo-3 | 2.23e-05 | 2 | 108 | 2 | ctd:C059715 | |
| Drug | NSC 114538 | 2.23e-05 | 2 | 108 | 2 | CID000073525 | |
| Drug | Phenothiazines | 2.23e-05 | 2 | 108 | 2 | ctd:D010640 | |
| Drug | CDCF | 3.64e-05 | 14 | 108 | 3 | CID000132525 | |
| Disease | prostate cancer (is_implicated_in) | 2.67e-06 | 117 | 98 | 6 | DOID:10283 (is_implicated_in) | |
| Disease | apolipoprotein M measurement | 5.75e-06 | 11 | 98 | 3 | EFO_0021945 | |
| Disease | primary sclerosing cholangitis (is_implicated_in) | 1.09e-05 | 2 | 98 | 2 | DOID:0060643 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ABCC1 SPTAN1 BCHE RFX2 GJA1 TAS2R13 BRCA2 ZNF277 UTP20 AKT1 AKT2 GALNT5 NIPBL PURG | 1.25e-05 | 1074 | 98 | 14 | C0006142 |
| Disease | cancer (implicated_via_orthology) | 3.23e-05 | 268 | 98 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Coronary Aneurysm | 3.27e-05 | 3 | 98 | 2 | C0010051 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.89e-05 | 20 | 98 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | Adenocarcinoma of prostate | 3.89e-05 | 20 | 98 | 3 | C0007112 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 4.52e-05 | 21 | 98 | 3 | DOID:8552 (is_implicated_in) | |
| Disease | malignant astrocytoma (is_marker_for) | 5.99e-05 | 23 | 98 | 3 | DOID:3069 (is_marker_for) | |
| Disease | type 1 diabetes mellitus, latent autoimmune diabetes in adults | 6.52e-05 | 4 | 98 | 2 | EFO_0009706, MONDO_0005147 | |
| Disease | Acute Q fever | 1.08e-04 | 5 | 98 | 2 | C0519066 | |
| Disease | Chronic Q Fever | 1.08e-04 | 5 | 98 | 2 | C1443892 | |
| Disease | Q Fever | 1.08e-04 | 5 | 98 | 2 | C0034362 | |
| Disease | narcolepsy-cataplexy syndrome, age at onset | 1.08e-04 | 5 | 98 | 2 | EFO_0004847, MONDO_0016158 | |
| Disease | HPV seropositivity | 1.08e-04 | 5 | 98 | 2 | EFO_0004510 | |
| Disease | level of coiled-coil domain-containing protein 134 in blood serum | 1.08e-04 | 5 | 98 | 2 | OBA_2044258 | |
| Disease | typhoid fever (is_implicated_in) | 1.08e-04 | 5 | 98 | 2 | DOID:13258 (is_implicated_in) | |
| Disease | Varicella zoster virus seropositivity | 1.08e-04 | 5 | 98 | 2 | EFO_0009340 | |
| Disease | Coxiella burnetii Infection | 1.08e-04 | 5 | 98 | 2 | C2973787 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.22e-04 | 29 | 98 | 3 | C0496920 | |
| Disease | mucocutaneous lymph node syndrome | 1.22e-04 | 76 | 98 | 4 | EFO_0004246 | |
| Disease | Ovarian Carcinoma | 1.35e-04 | 30 | 98 | 3 | C0029925 | |
| Disease | susceptibility to scarlet fever measurement | 1.42e-04 | 79 | 98 | 4 | EFO_0008409 | |
| Disease | allergic bronchopulmonary aspergillosis (is_implicated_in) | 1.62e-04 | 6 | 98 | 2 | DOID:13166 (is_implicated_in) | |
| Disease | antibody measurement, Epstein-Barr virus infection | 1.62e-04 | 6 | 98 | 2 | EFO_0000769, EFO_0004556 | |
| Disease | pneumocystosis (biomarker_via_orthology) | 1.62e-04 | 6 | 98 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | X-21471 measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0800818 | |
| Disease | pemphigus | 1.62e-04 | 6 | 98 | 2 | EFO_1000749 | |
| Disease | Drug toxicity | 1.80e-04 | 84 | 98 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.80e-04 | 84 | 98 | 4 | C0041755 | |
| Disease | chronic hepatitis C virus infection | 1.80e-04 | 33 | 98 | 3 | EFO_0004220 | |
| Disease | Bipolar Disorder | 1.94e-04 | 477 | 98 | 8 | C0005586 | |
| Disease | antinuclear antibody measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0005949 | |
| Disease | Anti-Helicobacter pylori IgG measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0009352 | |
| Disease | Cognition Disorders | 2.75e-04 | 38 | 98 | 3 | C0009241 | |
| Disease | IgG index | 3.02e-04 | 8 | 98 | 2 | EFO_0006929 | |
| Disease | PAX-interacting protein 1 measurement | 3.02e-04 | 8 | 98 | 2 | EFO_0801868 | |
| Disease | soluble CD163 measurement | 3.02e-04 | 8 | 98 | 2 | EFO_0020072 | |
| Disease | gdnf family receptor alpha-1 measurement | 3.02e-04 | 8 | 98 | 2 | EFO_0020400 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.46e-04 | 41 | 98 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.46e-04 | 41 | 98 | 3 | C0858252 | |
| Disease | high grade glioma (is_marker_for) | 3.71e-04 | 42 | 98 | 3 | DOID:3070 (is_marker_for) | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 3.87e-04 | 9 | 98 | 2 | EFO_0803299 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 3.87e-04 | 9 | 98 | 2 | EFO_0007790 | |
| Disease | inclusion body myositis | 3.87e-04 | 9 | 98 | 2 | EFO_0007323 | |
| Disease | amnestic disorder (implicated_via_orthology) | 3.87e-04 | 9 | 98 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | head and neck malignant neoplasia | 3.87e-04 | 9 | 98 | 2 | EFO_0006859 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 3.87e-04 | 9 | 98 | 2 | EFO_0801686 | |
| Disease | seropositivity measurement | 3.87e-04 | 9 | 98 | 2 | EFO_0007034 | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 3.87e-04 | 9 | 98 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | schizophrenia (is_marker_for) | 4.26e-04 | 44 | 98 | 3 | DOID:5419 (is_marker_for) | |
| Disease | peptidoglycan recognition protein 1 measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0020624 | |
| Disease | CCL19 measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0009415 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 4.83e-04 | 10 | 98 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | secreted and transmembrane protein 1 measurement | 4.83e-04 | 10 | 98 | 2 | EFO_0021852 | |
| Disease | Colorectal Carcinoma | 5.55e-04 | 702 | 98 | 9 | C0009402 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.86e-04 | 49 | 98 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | chronic bronchitis | 5.89e-04 | 11 | 98 | 2 | EFO_0006505 | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0020224 | |
| Disease | head and neck squamous cell carcinoma | 5.89e-04 | 11 | 98 | 2 | EFO_0000181 | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0800279 | |
| Disease | uveitis (implicated_via_orthology) | 5.89e-04 | 11 | 98 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of the head and neck | 6.98e-04 | 52 | 98 | 3 | C1168401 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 6.98e-04 | 52 | 98 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | rac GTPase-activating protein 1 measurement | 7.05e-04 | 12 | 98 | 2 | EFO_0801985 | |
| Disease | Huntington's disease (is_marker_for) | 7.38e-04 | 53 | 98 | 3 | DOID:12858 (is_marker_for) | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 8.22e-04 | 55 | 98 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 8.32e-04 | 13 | 98 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | Benign tumor of pancreas | 8.32e-04 | 13 | 98 | 2 | C0347284 | |
| Disease | Genetic chronic primary adrenal insufficiency | 8.32e-04 | 13 | 98 | 2 | Orphanet_101960 | |
| Disease | essential hypertension, age at diagnosis | 8.67e-04 | 56 | 98 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | systemic lupus erythematosus, COVID-19 | 9.60e-04 | 58 | 98 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | oral cavity cancer | 9.68e-04 | 14 | 98 | 2 | EFO_0005570 | |
| Disease | C-C motif chemokine 19 measurement | 9.68e-04 | 14 | 98 | 2 | EFO_0008047 | |
| Disease | X-21470 measurement | 9.68e-04 | 14 | 98 | 2 | EFO_0800817 | |
| Disease | oligoclonal band measurement, multiple sclerosis | 9.68e-04 | 14 | 98 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | ovarian neoplasm | 1.06e-03 | 134 | 98 | 4 | C0919267 | |
| Disease | Sjogren syndrome | 1.06e-03 | 60 | 98 | 3 | EFO_0000699 | |
| Disease | liver neoplasm | 1.11e-03 | 15 | 98 | 2 | EFO_1001513 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0009935 | |
| Disease | Churg-Strauss syndrome | 1.11e-03 | 15 | 98 | 2 | EFO_0007208 | |
| Disease | Malignant neoplasm of ovary | 1.15e-03 | 137 | 98 | 4 | C1140680 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 1.17e-03 | 62 | 98 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | pemphigus vulgaris | 1.27e-03 | 16 | 98 | 2 | EFO_0004719 | |
| Disease | gastroparesis | 1.27e-03 | 16 | 98 | 2 | EFO_1000948 | |
| Disease | Antihistamine use measurement | 1.44e-03 | 17 | 98 | 2 | EFO_0009943 | |
| Disease | high altitude adaptation | 1.44e-03 | 17 | 98 | 2 | EFO_0009105 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 1.44e-03 | 17 | 98 | 2 | EFO_0010559, GO_0035456 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 1.44e-03 | 17 | 98 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | X-21441 measurement | 1.44e-03 | 17 | 98 | 2 | EFO_0800814 | |
| Disease | Night blindness, congenital stationary | 1.44e-03 | 17 | 98 | 2 | C0339535 | |
| Disease | melanoma | 1.45e-03 | 248 | 98 | 5 | C0025202 | |
| Disease | serum IgG measurement | 1.61e-03 | 18 | 98 | 2 | EFO_0004565 | |
| Disease | tropical spastic paraparesis | 1.61e-03 | 18 | 98 | 2 | EFO_0007527 | |
| Disease | perceived unattractiveness to mosquitos measurement | 1.79e-03 | 72 | 98 | 3 | EFO_0008380 | |
| Disease | Pancreatic carcinoma | 1.80e-03 | 19 | 98 | 2 | C0235974 | |
| Disease | hepatitis B virus infection | 1.80e-03 | 19 | 98 | 2 | EFO_0004197 | |
| Disease | Alopecia | 1.80e-03 | 19 | 98 | 2 | C0002170 | |
| Disease | angiopoietin-1 receptor measurement | 1.80e-03 | 19 | 98 | 2 | EFO_0010600 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTKFSRLKAVYVPFW | 801 | Q15361 | |
| TWRPRYFLLKNDGTF | 21 | P31749 | |
| TWRPRYFLLKSDGSF | 21 | P31751 | |
| FLFTRKNPYRFLWGI | 326 | Q15758 | |
| KLRAQQCRFWTSFFP | 541 | P06276 | |
| ARLWFTYRRKFSPIG | 51 | Q8WYN0 | |
| FFSWTRPILRKGYRQ | 16 | P13569 | |
| FEKYNWPNRTVRVFT | 411 | Q9NY47 | |
| IRQPFSKWFVSKSEY | 191 | Q9Y2C3 | |
| RRFFKSPHFDGWYRQ | 486 | Q8NEG7 | |
| ENFAKKFPYRLSWLT | 21 | Q8N5N4 | |
| PRAVNGFSWRKTSKY | 231 | Q9Y485 | |
| RWINRLAYFSSCIPF | 126 | Q9BSY9 | |
| VASRLWFTYRKNFPA | 46 | Q9Y4P1 | |
| NWRPRYFLLKTDGSF | 21 | Q9Y243 | |
| IPYSRKWEFVSAFRQ | 416 | Q06278 | |
| AFSGIFNKRDFTRWP | 21 | Q1W4C9 | |
| FVVSFRKHYPWVQLS | 401 | Q96DU7 | |
| SFYPWVNILKISFKR | 251 | P26045 | |
| LYFKPSVFRCIALRW | 436 | Q6PRD1 | |
| RFPYYRRKFPAWQNS | 141 | Q8WXT5 | |
| RFPYYRRKFPAWQNS | 141 | Q6VB84 | |
| FQRTAWVFDDKYKRP | 131 | P05198 | |
| TDFYPAQIKVRWFRN | 151 | P05538 | |
| KAWSPVFRNYIKRAA | 626 | Q13144 | |
| YKSFFSALNWRKNPV | 691 | Q5JST6 | |
| RWTAPEAIQYRKFTS | 791 | P29323 | |
| GVKQEYRTWNPFRSK | 141 | A6NHQ2 | |
| YRTWNPFRSKLAAAI | 146 | A6NHQ2 | |
| RYFTWDKNRFPNPKR | 406 | Q8TET4 | |
| FTNPKVREWYSSLFA | 481 | Q8TET4 | |
| SYRNIFPIWALGRFS | 706 | P48449 | |
| DPSLVFSRKFYIAQW | 1666 | Q6KC79 | |
| FLYRFQIWRPITATF | 46 | Q9BUN8 | |
| GRNFLSTPQFLYRWL | 196 | Q9BUN8 | |
| VSQPRKHLFVWISFY | 346 | Q5T7B8 | |
| VKAYRFSISWSRIFP | 971 | P09848 | |
| ILKYFAWEPSFRDQV | 511 | Q92887 | |
| RWTAPEAIQYRKFTS | 801 | Q15375 | |
| FAYRWVARVFEISPF | 296 | Q16795 | |
| KFWKRAGFVPVYLRQ | 721 | Q9H0A0 | |
| RFPSWESRIYAVAKS | 546 | Q8IVE3 | |
| FSLGAFTRPYVDRLW | 391 | Q68CR7 | |
| KNFWRFIFRKNLPST | 71 | Q9UHB4 | |
| KLPYNWRRSIFAFLT | 871 | Q16827 | |
| AEIWSFYPSKFIQRD | 101 | Q86YG4 | |
| VRFKAYPQIRCTWTF | 371 | P36888 | |
| YPQIRCTWTFSRKSF | 376 | P36888 | |
| ARWVQDFRLKAYASP | 61 | Q8NB37 | |
| VTDFYPAQIKVRWFR | 151 | P01920 | |
| RAITTLPRVNQFWYK | 301 | Q9BZJ0 | |
| RRPFIFYRAQVGSWN | 151 | Q9NZH6 | |
| SSKVFRYDPRQNSWL | 346 | Q96M94 | |
| NSTRPARWYTKLGFF | 2781 | P51587 | |
| ARFRLWLTSYPSEKF | 3606 | Q8TD57 | |
| SVFTLDRFPLWYRQA | 791 | Q7Z3S7 | |
| SFKWYLENVFPDLRA | 791 | Q7Z7M9 | |
| YVRAWVVFKLSSAPR | 51 | Q15392 | |
| LETRWARPFYLAFVF | 6 | Q8N118 | |
| YDKSFPISHVRFWVL | 66 | P17302 | |
| TLSWFFKIPFVREYL | 136 | Q58HT5 | |
| LNFIAPSKREFYLWT | 641 | Q96BJ8 | |
| AAFWFRIYLRPGTTS | 46 | Q6ZNC8 | |
| AFSPYAVWQRKDILF | 266 | A6NNE9 | |
| QFWTGYFSSRPALKR | 386 | O00754 | |
| GRRWNKYFKSRRPLF | 71 | Q9BV81 | |
| PYFQSGRSRTKRSWV | 36 | Q9ULB5 | |
| YINPFVSFIDQRRWK | 611 | O95487 | |
| NWRPRFKFYHWTLSF | 606 | Q9Y666 | |
| YRNTITVPFKAWTRF | 296 | Q9UJV8 | |
| RWTAPEAIAYRKFSS | 841 | Q9UF33 | |
| YSFWERSRGIFLAPV | 91 | P33527 | |
| KNFRTRSWRAGSYLP | 321 | Q96CW9 | |
| AVSNWKPDSARVRYY | 196 | P21217 | |
| TFYRNPKLPFSRFWT | 196 | A8MW99 | |
| IASFSSPAFLYLKWR | 111 | Q9NYV9 | |
| NFSYPLFLKLRWRIT | 141 | P59534 | |
| ISIWSRNARYFPLLA | 1206 | O75691 | |
| FRKTWNPKYTLRSHF | 466 | Q13033 | |
| FKRTQYFRKNPGSLW | 271 | Q6P4A7 | |
| ARAAIPFIWRGKYFS | 16 | Q7L592 | |
| PKAARQFLLKWSFYS | 606 | P48378 | |
| PKAARQFLLKWSFYS | 591 | P48380 | |
| QEKPAWYRFLLTARF | 451 | Q96NR3 | |
| RFPYYRRKFPAWQNS | 141 | Q5VV16 | |
| RFPYYRRKFPAWQNS | 141 | Q3SYB3 | |
| ALPVRTSYKAFSTRW | 71 | Q8NEB9 | |
| ITERFAFYRDSPRKW | 101 | Q13461 | |
| AFYRDSPRKWQNSIR | 106 | Q13461 | |
| RNPRDVLVSGYFFWK | 121 | Q06520 | |
| RFYFENLWSRNSKPV | 396 | Q9UQM7 | |
| PIIYFFVGSFRKQWR | 276 | Q96LB1 | |
| ARYPNRFKLWFTLDH | 231 | Q9UHQ9 | |
| FERLPVFNKSAWRHY | 366 | Q15120 | |
| DLRFPWVAFFASKRI | 1241 | Q15047 | |
| VPVFKYSRWRAKGQA | 51 | O75891 | |
| TSYNDSAWRKRIPFS | 381 | Q8NA57 | |
| TPVFSFLDLTYWKRQ | 156 | Q9NP50 | |
| LSLFPLFQSSRWLRY | 66 | Q9NYW4 | |
| KRPLTAYNRFFKESW | 101 | P0CB47 | |
| WAQQYRERFIPFSKE | 66 | Q96AN5 | |
| ISPRYSWLFFLSRGI | 131 | Q6ZMD2 | |
| QIKSFRVASNPYTWF | 2156 | Q13813 | |
| KRKAPYFWSDFRDAF | 491 | Q6U841 | |
| FFRWLSRKYPSIIVN | 6 | Q9H0D6 | |
| PNLSRRFQYRWLEFS | 376 | P78562 | |
| ISKRWNFPSPFYRLH | 126 | P13686 | |
| NQRWFFEALKYPKFS | 156 | Q96MV1 | |
| AWIRFKKYNTSPRIF | 96 | A8MT19 | |
| YIFRLSQFRKPLQRW | 211 | Q96GW9 | |
| LYWRKRFTEQPITDF | 101 | Q9NRM2 | |
| PNIVRFYDSWKSVLR | 231 | Q96J92 | |
| RKFWSLQDYFRNPVQ | 236 | Q96FV9 | |
| QPWNRIQRRYFRFFT | 466 | O43156 | |
| QRQSPWRIYFRKEFF | 1276 | Q6PIF6 |